Talphera, Inc. (TLPH): Shareholders' Equity
$17.04M
As of 2025-12-31
$14.41M
As of 2026-06-30
-7.9%
3-year compound annual growth
-6.4%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.04M | +112.9% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $8.00M | -43.3% | 2026-03-23, Balance as of period end |
| 2023-12-31 | $14.11M | -35.3% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $21.81M | n/m | 2024-03-06, Balance as of period end |
| 2021-12-31 | -$35.89M | n/m | 2023-03-31, Balance as of period end |
| 2020-12-31 | -$55.75M | n/m | 2022-03-10, Balance as of period end |
| 2019-12-31 | -$41.42M | n/m | 2021-03-15, Balance as of period end |
| 2018-12-31 | $4.25M | n/m | 2021-03-15, Balance as of period end |
| 2017-12-31 | -$36.51M | n/m | 2020-03-16, Balance as of period end |
| 2016-12-31 | -$5.34M | n/m | 2019-03-07, Balance as of period end |
| 2015-12-31 | $33.11M | -29.0% | 2018-03-09, Balance as of period end |
| 2014-12-31 | $46.66M | -36.2% | 2017-03-03, Balance as of period end |
| 2013-12-31 | $73.16M | +116.1% | 2016-03-07, Balance as of period end |
| 2012-12-31 | $33.85M | +93.8% | 2015-03-13, Balance as of period end |
| 2011-12-31 | $17.47M | n/m | 2014-03-17, Balance as of period end |
| 2010-12-31 | -$65.89M | n/m | 2013-03-12, Balance as of period end |
| 2009-12-31 | -$52.99M | n/m | 2013-03-12, Balance as of period end |
| 2008-12-31 | -$33.34M | n/m | 2013-03-12, Balance as of period end |
| 2007-12-31 | -$13.19M | n/m | 2013-03-12, Balance as of period end |
| 2006-12-31 | -$3.71M | n/m | 2013-03-12, Balance as of period end |
| 2005-12-31 | -$40.0K | n/a | 2013-03-12, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Talphera, Inc. (TLPH) | 2025-12-31 | $17.04M | +112.9% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $12.61M | +196.1% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | -$1.83M | n/m |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $248.20M | -35.2% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$10.26M | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$17.51M | n/m |
| Altimmune, Inc. (ALT) | 2025-12-31 | $224.89M | +82.1% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$2.13M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $8.54M | +368.4% |
Compare TLPH, IBO, JUNS, LYEL side by side · Screen every company in Pharmaceutical Preparations ↗